| Year |
Citation |
Score |
| 2009 |
Lavie MC, Feydy A, Gossec L, Lavie F, Guerini H, Ayral X, Briot K, Kolta S, Dougados M, Drapé JL. Valeur diagnostique de l’IRM et de l’echographie-doppler puissance des talons au cours de la spondylarthropathie Journal De Radiologie. 90: 1325. DOI: 10.1016/S0221-0363(09)75270-9 |
0.355 |
|
| 2008 |
Sellam J, Miceli-Richard C, Gottenberg JE, Proust A, Ittah M, Lavie F, Loiseau P, Mariette X. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Rheumatology (Oxford, England). 47: 437-41. PMID 18296721 DOI: 10.1093/Rheumatology/Ken013 |
0.761 |
|
| 2008 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 67: 185-92. PMID 18201372 DOI: 10.1111/J.1365-3083.2007.02049.X |
0.78 |
|
| 2007 |
Pavy S, Dernis E, Lavie F, Maillefert JF, Mariette X, Schaeverbeke T, Cantagrel A, Claudepierre P, Flipo RM, Goupille P, Le Loet X, Saraux A, Tebib J, Wendling D, Combe B. Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 338-45. PMID 17591453 DOI: 10.1016/J.Jbspin.2007.04.001 |
0.387 |
|
| 2007 |
Lavie F, Pavy S, Dernis E, Goupille P, Cantagrel A, Tebib J, Claudepierre P, Flipo RM, Le Loët X, Maillefert JF, Mariette X, Saraux A, Schaeverbeke T, Wendling D, Combe B. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 346-52. PMID 17590370 DOI: 10.1016/J.Jbspin.2007.04.003 |
0.386 |
|
| 2007 |
Dernis E, Lavie F, Pavy S, Wendling D, Flipo RM, Saraux A, Cantagrel A, Claudepierrre P, Goupille P, Le Loët X, Maillefert JF, Mariette X, Schaeverbeke T, Tebib J, Combe B. Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 330-7. PMID 17590366 DOI: 10.1016/J.Jbspin.2007.04.002 |
0.397 |
|
| 2007 |
Terrier B, Ittah M, Tourneur L, Louache F, Soumelis V, Lavie F, Casadevall N, Candon S, Hummel A, Mariette X, Buzyn A. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica. 92: e20-3. PMID 17405749 DOI: 10.3324/Haematol.11031 |
0.754 |
|
| 2007 |
Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7. PMID 17185325 DOI: 10.1136/Ard.2006.065656 |
0.746 |
|
| 2007 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Annals of the Rheumatic Diseases. 66: 700-3. PMID 17040963 DOI: 10.1136/Ard.2006.060772 |
0.773 |
|
| 2007 |
Dernis E, Lavie F, Salliot C, Flipo R, Saraux A, Maillefert J, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loët X, et al. Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique périphérique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts Revue Du Rhumatisme. 74: 31-38. DOI: 10.1016/S1169-8330(07)78645-3 |
0.376 |
|
| 2007 |
Lavie F, Salliot C, Dernis E, Claudepierre P, Schaeverbeke T, Tebib J, Goupille P, Cantagrel A, Flipo RM, Gaudin P, Loët XL, Maillefert J, Paul C, Saraux A, Wendling D, et al. Pronostic et suivi du rhumatisme psoriasique de forme périphérique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts: Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion Revue Du Rhumatisme. 74: 23-30. DOI: 10.1016/S1169-8330(07)78644-1 |
0.375 |
|
| 2007 |
Salliot C, Dernis E, Lavie F, Cantagrel A, Gaudin P, Wendling D, Claudepierre P, Flipo R, Goupille P, Loët XL, Maillefert J, Paul C, Saraux A, Schaeverbeke T, Tebib J, et al. Pronostic et suivi du rhumatisme psoriasique de forme périphérique : élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l'opinion d'experts Revue Du Rhumatisme. 74: 15-22. DOI: 10.1016/S1169-8330(07)78643-X |
0.364 |
|
| 2007 |
Dernis E, Lavie F, Salliot C, Flipo R, Saraux A, Maillefert J, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loet X, et al. Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique de forme périphérique: élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l'opinion d'experts Revue Du Rhumatisme. 74: 1030. DOI: 10.1016/J.Rhum.2007.10.579 |
0.374 |
|
| 2007 |
Sellam J, Miceli Richard C, Proust A, Ittah M, Lavie F, Gottenberg J, Loiseau P, Mariette X. Le gène Id3 est-il impliqué dans le syndrome de Sjögren? Revue Du Rhumatisme. 74: 1019-1020. DOI: 10.1016/J.Rhum.2007.10.553 |
0.759 |
|
| 2006 |
Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, Nordmann P, Cagnard N, Sibilia J, Mariette X. Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. Arthritis and Rheumatism. 54: 2026-8. PMID 16732567 DOI: 10.1002/Art.21906 |
0.74 |
|
| 2006 |
Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R51. PMID 16507175 DOI: 10.1186/Ar1912 |
0.763 |
|
| 2006 |
Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R30. PMID 16507129 DOI: 10.1186/Ar1884 |
0.761 |
|
| 2006 |
Lavie F, Ittah M, Miceli-Richard C, Gottenberg J, Sellam J, Mariette X. Expression anormale de BAFF au sein des monocytes et lymphocytes T circulants de patients ayant un syndrome de Sjögren primitif Revue Du Rhumatisme. 73: 1227. DOI: 10.1016/J.Rhum.2006.10.564 |
0.781 |
|
| 2006 |
Ittah M, Miceli-Richard C, Gottenberg J, Lavie F, Sellam J, Mariette X. Induction de la cytokine BAFF (B Cell-Activating Factor of the TNF family) par les cellules épithéliales de glandes salivaires après infection virale Revue Du Rhumatisme. 73: 1201-1202. DOI: 10.1016/J.Rhum.2006.10.487 |
0.789 |
|
| 2006 |
Gottenberg J, Jacques S, Ittah M, Miceli-Richard C, Lavie F, Sellam J, Mariette X. Un nouveau rôle pathogène des interférons au cours des maladies auto-immunes: l'augmentation du rapport BAFF/delta-BAFF dans les cellules cibles de l'auto-immunité Revue Du Rhumatisme. 73: 1201. DOI: 10.1016/J.Rhum.2006.10.485 |
0.743 |
|
| 2006 |
Sellam J, Miceli-Richard C, Gottenberg J, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Expression du récepteur de BAFF (B cell Activator Factor of TNF Family), BAFF-R, au cours du syndrome de Sjögren primitif et du lupus systémique Revue Du Rhumatisme. 73: 1200. DOI: 10.1016/J.Rhum.2006.10.483 |
0.754 |
|
| 2006 |
Lavie F, Miceli-Richard C, Ittah M, Gottenberg J, Sellam J, Mariette X. Augmentation paradoxale de BAFF après déplétion lymphocytaire B induite par le rituximab dans les maladies auto-immunes systémiques Revue Du Rhumatisme. 73: 1092. DOI: 10.1016/J.Rhum.2006.10.171 |
0.769 |
|
| 2006 |
Dernis E, Lavie F, Pavy S, Wendling D, Flipo R-, Saraux A, Claudepierre P, Combe B. L'évaluation clinique et biologique dans la prise en charge et le suivi des personnes atteintes de spondylarthrite ankylosante : Etablissement de recommandations pour la pratique clinique Revue Du Rhumatisme. 73: 1070. DOI: 10.1016/J.Rhum.2006.10.114 |
0.353 |
|
| 2005 |
Terrier B, Lavie F, Miceli-Richard C, Azria A, Mariette X. Focal myositis with fasciitis and vasculitis revealing chronic lymphocytic leukaemia. Rheumatology (Oxford, England). 44: 1324-6. PMID 15941726 DOI: 10.1093/Rheumatology/Keh706 |
0.387 |
|
| 2005 |
Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. Journal of Autoimmunity. 24: 235-42. PMID 15848046 DOI: 10.1016/J.Jaut.2005.01.015 |
0.37 |
|
| 2005 |
Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, Sibilia J, Mariette X. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome Annals of the Rheumatic Diseases. 64: 1050-1055. PMID 15640273 DOI: 10.1136/Ard.2004.030643 |
0.478 |
|
| 2004 |
Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. The Journal of Pathology. 202: 496-502. PMID 15095277 DOI: 10.1002/Path.1533 |
0.527 |
|
| 2003 |
Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Annals of the Rheumatic Diseases. 62: 168-71. PMID 12525388 DOI: 10.1136/Ard.62.2.168 |
0.522 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2005 |
Salliot C, Lavie F, Azria A, Clerc D, Miquel A, Mariette X. Retroperitoneal fibrosis secondary to spondylodiscitis after infection with Prevotella. The Journal of Rheumatology. 32: 957-8. PMID 15868637 |
0.296 |
|
| 2012 |
Sieper J, van der Heijde D, Dougados M, Brown LS, Lavie F, Pangan AL. Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 71: 700-6. PMID 22128084 DOI: 10.1136/Annrheumdis-2011-200358 |
0.282 |
|
| 2012 |
Feydy A, Lavie-Brion MC, Gossec L, Lavie F, Guerini H, Nguyen C, Rannou F, Drapé JL, Dougados M. Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Annals of the Rheumatic Diseases. 71: 498-503. PMID 21949008 DOI: 10.1136/Annrheumdis-2011-200336 |
0.231 |
|
| 2008 |
Keen HI, Lavie F, Wakefield RJ, D'Agostino MA, Hammer HB, Hensor E, Pendleton A, Kane D, Guerini H, Schueller-Weidekamm C, Kortekaas MC, Birrel F, Kloppenburg M, Stamm T, Watt I, et al. The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis. Annals of the Rheumatic Diseases. 67: 651-5. PMID 17704062 DOI: 10.1136/Ard.2007.077081 |
0.209 |
|
| 2023 |
Schett G, Chen W, Gao S, Chakravarty SD, Shawi M, Lavie F, Zimmermann M, Sharaf M, Coates LC, Siebert S. Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. Arthritis Research & Therapy. 25: 170. PMID 37715280 DOI: 10.1186/s13075-023-03158-9 |
0.209 |
|
| 2023 |
Schett G, Chen W, Gao S, Chakravarty SD, Shawi M, Lavie F, Zimmermann M, Sharaf M, Coates LC, Siebert S. Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. Arthritis Research & Therapy. 25: 150. PMID 37587493 DOI: 10.1186/s13075-023-03125-4 |
0.193 |
|
| 2002 |
Lavie F, Rozenberg S, Coutaux A, Koeger AC, Bourgeois P, Fautrel B. Bronchiectasis in a patient with CREST syndrome. Joint, Bone, Spine : Revue Du Rhumatisme. 69: 515-8. PMID 12477240 |
0.192 |
|
| 2024 |
Siebert S, Coates LC, Schett G, Raychaudhuri SP, Chen W, Gao S, Seridi L, Chakravarty SD, Shawi M, Lavie F, Sharaf M, Zimmermann M, Kollmeier AP, Xu XL, Rahman P, et al. Modulation of IL-23 Signaling With Guselkumab in Biologic-Naïve Patients Versus TNF Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 38253404 DOI: 10.1002/art.42803 |
0.159 |
|
| 2023 |
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Sharaf M, Theander E, Smolen JS. Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study. Arthritis Research & Therapy. 25: 109. PMID 37353788 DOI: 10.1186/s13075-023-03058-y |
0.155 |
|
| 2023 |
Van Kuijk AWR, Nurmohamed MT, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Sharaf M, Noël W, Theander E, Smolen JS, Gossec L, van der Horst-Bruinsma IE. Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. Rheumatology (Oxford, England). PMID 36810788 DOI: 10.1093/rheumatology/kead089 |
0.145 |
|
| 2022 |
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, et al. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. The Lancet. Gastroenterology & Hepatology. 7: 294-306. PMID 35120656 DOI: 10.1016/S2468-1253(21)00474-X |
0.136 |
|
| 2023 |
Mease PJ, Gottlieb AB, Ogdie A, McInnes IB, Chakravarty SD, Rampakakis E, Kollmeier A, Xu XL, Shawi M, Lavie F, Kishimoto M, Rahman P. Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment. Clinical Rheumatology. PMID 37787903 DOI: 10.1007/s10067-023-06745-y |
0.135 |
|
| 2022 |
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Theander E, Smolen JS. Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study. Annals of the Rheumatic Diseases. PMID 35210262 DOI: 10.1136/annrheumdis-2021-221640 |
0.133 |
|
| 2023 |
Peyrin-Biroulet L, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravatà I, Lavie F, Daperno M, Lukáš M, Armuzzi A, et al. Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST. Alimentary Pharmacology & Therapeutics. PMID 38036946 DOI: 10.1111/apt.17751 |
0.133 |
|
| 2022 |
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Sharaf M, Theander E, Smolen JS. Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the Rheumatic Diseases. PMID 36600178 DOI: 10.1136/ard-2022-222879 |
0.127 |
|
| 2019 |
Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke M, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Castiglia A, Lavie F, Paul C. 银屑病患者的述情障碍逆转 British Journal of Dermatology. 180: e61-e61. DOI: 10.1111/bjd.17492 |
0.12 |
|
| 2015 |
Paul C, Girolomoni G, Radtke MA, Sampogna F, Spuls P, Kirby B, Brunori M, Smirnov P, Bergmans P, Rundle J, Lavie F, Puig L. Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration: Epidepso Multicentre Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A425-6. PMID 26532393 DOI: 10.1016/j.jval.2015.09.583 |
0.114 |
|
| 2018 |
Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Castiglia A, Lavie F, Paul C. Reversibility of alexithymia with effective treatment of moderate to severe psoriasis: longitudinal data from EPIDEPSO. The British Journal of Dermatology. PMID 30269346 DOI: 10.1111/bjd.17259 |
0.106 |
|
| 2023 |
Gottlieb AB, McInnes IB, Rahman P, Kollmeier AP, Xu XL, Jiang Y, Sheng S, Shawi M, Chakravarty SD, Lavie F, Mease PJ. Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis. Rmd Open. 9. PMID 36828643 DOI: 10.1136/rmdopen-2022-002789 |
0.104 |
|
| 2014 |
Paul C, Puig L, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E, Lavie F, Mistry S, Bergmans P, Barker J, Reich K. Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). The British Journal of Dermatology. 170: 425-34. PMID 24116959 DOI: 10.1111/bjd.12646 |
0.101 |
|
| 2016 |
Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Lavie F, Paul C. Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study. The British Journal of Dermatology. PMID 27995617 DOI: 10.1111/bjd.15243 |
0.099 |
|
| 2022 |
Gladman DD, Mease PJ, Bird P, Soriano ER, Chakravarty SD, Shawi M, Lavie F, Gong C, Leibowitz E, Poddubnyy D, Tam LS, Helliwell PS, Kavanaugh A, Deodhar AA, Østergaard M, et al. Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the Rheumatic Diseases. PMID 35487679 DOI: 10.1136/annrheumdis-2022-222161 |
0.098 |
|
| 2009 |
Dernis E, Lavie F, Salliot C, Flipo RM, Saraux A, Maillefert JF, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loët X, et al. Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 76: 524-31. PMID 19457691 DOI: 10.1016/J.Jbspin.2009.03.002 |
0.093 |
|
| 2009 |
Lavie F, Salliot C, Dernis E, Claudepierre P, Schaeverbeke T, Tebib J, Goupille P, Cantagrel A, Flipo RM, Gaudin P, Le Loët X, Maillefert JF, Paul C, Saraux A, Wendling D, et al. Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 76: 540-6. PMID 19457693 DOI: 10.1016/J.Jbspin.2009.03.003 |
0.091 |
|
| 2023 |
Gossec L, Theander E, Chakravarty SD, Bergmans P, Lavie F, Noël W, Sharaf M, Siebert S, Smolen JS. Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study. Arthritis Research & Therapy. 25: 100. PMID 37296456 DOI: 10.1186/s13075-023-03078-8 |
0.083 |
|
| 2023 |
Lavie F, Rooney T. Hurdles in new drug development in rheumatic diseases. Joint Bone Spine. 91: 105672. PMID 38042361 DOI: 10.1016/j.jbspin.2023.105672 |
0.08 |
|
| 2009 |
Salliot C, Dernis E, Lavie F, Cantagrel A, Gaudin P, Wendling D, Claudepierre P, Flipo RM, Goupille PM, Le Loët X, Maillefert JF, Paul C, Saraux A, Schaeverbeke T, Tebib J, et al. Diagnosis of peripheral psoriatic arthritis: recommendations for clinical practice based on data from the literature and experts opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 76: 532-9. PMID 19467898 DOI: 10.1016/J.Jbspin.2009.03.004 |
0.076 |
|
| 2019 |
Sweiti H, Wiegand F, Bug C, Vogel M, Lavie F, Winiger-Candolfi I, Schuier M. Physicians in the pharmaceutical industry: their roles, motivations, and perspectives. Drug Discovery Today. PMID 31158509 DOI: 10.1016/j.drudis.2019.05.021 |
0.036 |
|
| 2019 |
Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke M, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Castiglia A, Lavie F, Paul C. Alexithymia reversion in psoriasis British Journal of Dermatology. 180: e48-e48. DOI: 10.1111/bjd.17479 |
0.028 |
|
| Hide low-probability matches. |